RecruitingPhase 2NCT06686043
HPV Vaccine, Imiquimod, and Metformin Combination Trial
Studying Vaginal carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Baylor College of Medicine
- Principal Investigator
- Jan S Sunde, MD, M.DBaylor College of Medicine
- Intervention
- HPV vaccine, Imiquimod, and metformin combination therapy(drug)
- Enrollment
- 85 enrolled
- Eligibility
- 18-64 years · FEMALE
- Timeline
- 2024 – 2028
Study locations (2)
- Baylor St. Luke's Medical Center- Dan L. Duncan Comprehensive Cancer Center, Houston, Texas, United States
- Harris Health Smith Clinic, Houston, Texas, United States
Collaborators
Harris Health · Dan L Duncan Comprehensive Cancer Center · Baylor St. Luke's Medical Center
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06686043 on ClinicalTrials.govOther trials for Vaginal carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07407647Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal CancerOhio State University Comprehensive Cancer Center
- ACTIVE NOT RECRUITINGNCT04713618Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation TherapyOhio State University Comprehensive Cancer Center
- ACTIVE NOT RECRUITINGNCT00791635Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic CancerM.D. Anderson Cancer Center